Israeli veterans can now inhale prescribed medical cannabis from a cartridge, instead of smoking it.
The Ministry of Defense has signed an agreement with Syqe Medical, developer of the technology, to supply its specialized inhaler.
Veterans suffering PTSD or chronic pain can control the amount of cannabis they inhale, with no need to handle the cannabis flowers, no adverse effects from heavy smoke, and no risk of consuming too much and getting high.
They simply insert a cartridge into the inhaler, which is ready for immediate use. Each cartridge contains 60 uniform doses of pharmaceutical-grade, raw cannabis flowers from a Dutch company.
Hagit Kamin, CEO of SyqeAir, said: “We are proud of the strategic partnership with the Ministry of Defense and the opportunity to bring our breakthrough technology, the SyqeAir Inhaler, to veterans in need of medical cannabis treatment.
“It is our privilege to help veterans who mainly suffer from chronic pain and PTSD to establish a functioning daily routine for themselves, and we are honored for the opportunity to make a positive impact on their lives.”
Jacob Vogel, Director of Global Sales and Business Development, said: “It’s been a long journey to get to this point, but it’s truly rewarding to see the impact that the SyqeAir Inhaler has on the lives of our patients.
“The fact that we are able to provide veterans with a treatment option that has a real, positive impact on their daily functionality makes all the hard work worth it. We hope this partnership will serve as a model for other countries to follow in providing veterans with the best possible medical care.”
The SyqeAir Inhaler has been validated by three clinical trials, and is approved for use in Canada, as well as in European countries.
Syqe Medical was founded in 2011, and is based in Tel Aviv.
Facebook comments